pazopanib and Esthesioneuroblastoma--Olfactory

pazopanib has been researched along with Esthesioneuroblastoma--Olfactory* in 1 studies

Other Studies

1 other study(ies) available for pazopanib and Esthesioneuroblastoma--Olfactory

ArticleYear
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation.
    JCO precision oncology, 2021, Volume: 5

    Topics: Aged; Esthesioneuroblastoma, Olfactory; Female; Fumarate Hydratase; Humans; Indazoles; Mutation; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Pyrimidines; Remission Induction; Retreatment; Sulfonamides; Time Factors

2021